Keywords: Gout, EULAR presentations, Krystexxa, Savient Pharma, Lesinurad, Allopurinol

Several abstracts on gout reveal true burden of disease and highlight promising new treatments

Article | 27 May 2011

Print This

New studies on gout were presented this week at EULAR, the Annual Congress of the European League Against Rheumatism, taking ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in